El tratamiento intralesional de Leishmaniasis cutánea es seguro frente al riesgo de complicaciones mucosas?

Objective: to assess the long-term safety against the risk of mucosal complications of intralesional pentavalent antimonials (PA) in patients with cutaneous leishmaniasis compared to the systemic use of PA. Methods: retrospective longitudinal quantitative observational study. A total of 66 clinical...

Descripción completa

Detalles Bibliográficos
Publicado en:Gaceta Médica Boliviana Vol. 43; no. 1; pp. 18 - 23
Autores principales: Limachi-Choque, Jhonny Wilson, Rojas-Cabrera, Ernesto, Verduguez-Orellana, Aleida, Eid-Rodríguez, Daniel
Formato: Artículo
Publicado: Universidad Mayor de San Simon, Facultad de Medicina ene-jun2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=145325575&site=ehost-live
header:
  @attributes:
    shortDbName: lth
    uiTerm: 145325575
    longDbName: MedicLatina
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        10122966
        ECYT
      jtl: Gaceta Médica Boliviana
      issn: 10122966
      maglogo: N
    pubinfo:
      dt: ene-jun2020
      vid: 43
      iid: 1
      pid: 74695
      pub: Universidad Mayor de San Simon, Facultad de Medicina
    artinfo:
      ui:
        145325575
        10.47993/gmb.v43i1.13
      ppf: 18
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
            size: 454KB
      tig:
        atl: El tratamiento intralesional de Leishmaniasis cutánea es seguro frente al riesgo de complicaciones mucosas?
      aug:
        au:
          Limachi-Choque, Jhonny Wilson
          Rojas-Cabrera, Ernesto
          Verduguez-Orellana, Aleida
          Eid-Rodríguez, Daniel
        affil: Centro Universitario de Medicina Tropical, UMSS
      sug:
      keyword:
        intralesional treatment
        mucosal leishmaniasis
        systemic treatment
        treatment safety
        intralesional treatment
        Leishmaniasis mucosa
        mucosal leishmaniasis
        systemic treatment
        tratamiento intralesional
        tratamiento sistémico
        treatment safety
      ab:
        Objective: to assess the long-term safety against the risk of mucosal complications of intralesional pentavalent antimonials (PA) in patients with cutaneous leishmaniasis compared to the systemic use of PA. Methods: retrospective longitudinal quantitative observational study. A total of 66 clinical records of patients diagnosed with cutaneous leishmaniasis in Isiboro Secure Park were analyzed between 2012 and 2016. A total of 46 systemic and 20 intralesional treatments were evaluated. Results: clinical evaluation 4-7 years after healing of leishmaniasis skin lesions showed no development of mucosal lesions. Likewise, no therapeutic failures, relapses or short-term adverse effects were reported. Conclusions: intralesional treatment was safe and effective in the long term and is a reliable option for the treatment of cutaneous leishmaniasis avoiding the future complications of the disease.
        Objetivo: evaluar la seguridad a largo plazo frente al riesgo de complicaciones mucosas del uso intralesional de antimoniales pentavalentes en pacientes con Leishmaniasis cutánea comparado con el uso sistémico de los mismos. Métodos: estudio observacional, cuantitativo de tipo longitudinal retrospectivo. Se analizó un total de 66 registros clínicos de pacientes, con diagnóstico de Leishmaniasis cutánea del parque Isiboro Secure durante el periodo 2012 a 2016. Se evaluó un total de 46 tratamientos sistémicos y 20 intralesionales. Resultados: la evaluación clínica realizada entre 4 y 7 años posteriores a la cicatrización de las lesiones cutáneas de Leishmaniasis mostró la ausencia de desarrollo de lesiones mucosas. Así mismo no se reportó fallas terapéuticas, recidivas ni efectos adversos a corto plazo. Conclusiones: el tratamiento intralesional fue seguro y eficaz a largo plazo y es una opción confiable para el tratamiento de Leishmaniasis cutánea evitando las complicaciones futuras de la enfermedad.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: Spanish
    refInfo:
    copyright:
      @attributes:
        flag: Y
      custom: Copyright of Gaceta Médica Boliviana is the property of Universidad Mayor de San Simon, Facultad de Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use.
      item: Gaceta Médica Boliviana
      holder: Universidad Mayor de San Simon, Facultad de Medicina
      dt:
        @attributes:
          year: 2020
    holdings:
      @attributes:
        islocal: N